{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:58:51Z","timestamp":1792252731717,"version":"4.4.0"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Models to predict Parkinson\u2019s disease (PD) incorporating alterations of gut microbiome (GM) composition have been reported with varying success.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To assess the utility of GM compositional changes combined with macronutrient intake to develop a predictive model of PD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a cross-sectional analysis of the GM and nutritional intake in 103 PD patients and 81 household controls (HCs). GM composition was determined by 16S amplicon sequencing of the V3-V4 region of bacterial ribosomal DNA isolated from stool. To determine multivariate disease-discriminant associations, we developed two models using Random Forest and support-vector machine (SVM) methodologies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Using updated taxonomic reference, we identified significant compositional differences in the GM profiles of PD patients in association with a variety of clinical PD characteristics. Six genera were overrepresented and eight underrepresented in PD patients relative to HCs, with the largest difference being overrepresentation of <jats:italic>Lactobacillaceae<\/jats:italic> at family taxonomic level. Correlation analyses highlighted multiple associations between clinical characteristics and select taxa, whilst constipation severity, physical activity and pharmacological therapies associated with changes in beta diversity. The random forest model of PD, incorporating taxonomic data at the genus level and carbohydrate contribution to total energy demonstrated the best predictive capacity [Area under the ROC Curve (AUC) of 0.74].<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The notable differences in GM diversity and composition when combined with clinical measures and nutritional data enabled the development of a predictive model to identify PD. These findings support the combination of GM and nutritional data as a potentially useful biomarker of PD to improve diagnosis and guide clinical management.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2022.881872","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T11:52:36Z","timestamp":1652269956000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Nutritional Intake and Gut Microbiome Composition Predict Parkinson\u2019s Disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Michal","family":"Lubomski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangnan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Y. H.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn M.","family":"Sue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/bf02056950","article-title":"A constipation scoring system to simplify evaluation and management of constipated patients.","volume":"39","author":"Agachan","year":"1996","journal-title":"Dis. Colon. Rectum."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00427-6","article-title":"Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson\u2019s disease.","volume":"16","author":"Aho","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"B3","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","article-title":"Gut microbiota in Parkinson\u2019s disease: temporal stability and relations to disease progression.","volume":"44","author":"Aho","year":"2019","journal-title":"EBioMedicine"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-020-00775-7","article-title":"Parkinson\u2019s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions.","volume":"18","author":"Baldini","year":"2020","journal-title":"BMC Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1017\/S1368980007001103","article-title":"Validity of carbohydrate, glycaemic index and glycaemic load data obtained using a semi-quantitative food-frequency questionnaire.","volume":"11","author":"Barclay","year":"2008","journal-title":"Public Health Nutr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/mds.27581","article-title":"Unraveling gut microbiota in Parkinson\u2019s disease and atypical parkinsonism.","volume":"34","author":"Barichella","year":"2018","journal-title":"Mov. Disord."},{"key":"B7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/mds.27581","article-title":"Unraveling gut microbiota in Parkinson\u2019s disease and atypical parkinsonism.","volume":"34","author":"Barichella","year":"2019","journal-title":"Mov. Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression.","volume":"4","author":"Beck","year":"1961","journal-title":"Arch. Gen. Psychiatry"},{"key":"B9","article-title":"Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson\u2019s disease patients.","volume":"9","author":"Bedarf","year":"2017","journal-title":"Genome Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"S297","DOI":"10.3233\/JPD-191711","article-title":"Increasing comparability and utility of gut microbiome studies in Parkinson\u2019s disease: a systematic review.","volume":"9","author":"Boertien","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004773","article-title":"Functional diversity of carbohydrate-active enzymes enabling a bacterium to ferment plant biomass.","volume":"10","author":"Boutard","year":"2014","journal-title":"PLoS Genet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/mdc3.12840","article-title":"Gut vibes in Parkinson\u2019s disease: the microbiota-gut-brain axis.","volume":"6","author":"Bullich","year":"2019","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.4103\/1673-5374.295270","article-title":"The emerging role of probiotics in neurodegenerative diseases: new hope for Parkinson\u2019s disease?","volume":"16","author":"Castelli","year":"2021","journal-title":"Neural Regen. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/mds.21596","article-title":"The metric properties of a novel non-motor symptoms scale for Parkinson\u2019s disease: Results from an international pilot study.","volume":"22","author":"Chaudhuri","year":"2007","journal-title":"Mov. Disord."},{"key":"B15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","article-title":"The role of short-chain fatty acids in microbiota-gut-brain communication.","volume":"16","author":"Dalile","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/mds.28004","article-title":"Implications of the gut microbiome in Parkinson\u2019s disease.","volume":"35","author":"Elfil","year":"2020","journal-title":"Mov. Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.anaerobe.2014.08.010","article-title":"Butyricicoccus pullicaecorum, a butyrate producer with probiotic potential, is intrinsically tolerant to stomach and small intestine conditions.","volume":"30","author":"Geirnaert","year":"2014","journal-title":"Anaerobe"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement disorder society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results.","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00839","article-title":"Altered gut microbiome in Parkinson\u2019s disease and the influence of lipopolysaccharide in a human alpha-synuclein over-expressing mouse model.","volume":"13","author":"Gorecki","year":"2019","journal-title":"Front. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1079\/phn2005898","article-title":"The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity.","volume":"9","author":"Hagstromer","year":"2006","journal-title":"Public Health Nutr."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142164","article-title":"Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson\u2019s disease.","volume":"10","author":"Hasegawa","year":"2015","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","article-title":"Parkinson\u2019s disease: a dual-hit hypothesis.","volume":"33","author":"Hawkes","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/mds.27105","article-title":"The nasal and gut microbiome in Parkinson\u2019s disease and idiopathic rapid eye movement sleep behavior disorder.","volume":"33","author":"Heintz-Buschart","year":"2018","journal-title":"Mov. Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ana.25788","article-title":"Gut microbiome signatures of risk and prodromal markers of Parkinson disease.","volume":"88","author":"Heinzel","year":"2020","journal-title":"Ann. Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","article-title":"Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome.","volume":"32","author":"Hill-Burns","year":"2017","journal-title":"Mov. Disord."},{"key":"B26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.brainres.2017.04.019","article-title":"Gut microbiota in Parkinson disease in a northern German cohort.","volume":"1667","author":"Hopfner","year":"2017","journal-title":"Brain Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","article-title":"Brain-first versus body-first Parkinson\u2019s disease: a multimodal imaging case-control study.","volume":"143","author":"Horsager","year":"2020","journal-title":"Brain"},{"key":"B28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases.","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ageing\/26.5.353","article-title":"The Parkinson\u2019s Disease Questionnaire (PDQ-39): development and validation of a Parkinson\u2019s disease summary index score.","volume":"26","author":"Jenkinson","year":"1997","journal-title":"Age Ageing"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01184","article-title":"Analysis of the gut microflora in patients with Parkinson\u2019s disease.","volume":"13","author":"Jin","year":"2019","journal-title":"Front. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.756951","article-title":"Changes in the gut microbiome and predicted functional metabolic effects in an australian Parkinson\u2019s disease cohort.","volume":"15","author":"Kenna","year":"2021","journal-title":"Front. Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","article-title":"Colonic bacterial composition in Parkinson\u2019s disease.","volume":"30","author":"Keshavarzian","year":"2015","journal-title":"Mov. Disord."},{"key":"B33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/bs.pbr.2020.01.004","article-title":"The gut microbiome in Parkinson\u2019s disease: a culprit or a bystander?","volume":"252","author":"Keshavarzian","year":"2020","journal-title":"Prog Brain Res."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks808","article-title":"Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies.","volume":"41","author":"Klindworth","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3109\/00365529709011203","article-title":"Stool form scale as a useful guide to intestinal transit time.","volume":"32","author":"Lewis","year":"1997","journal-title":"Scand. J. Gastroenterol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s11427-016-9001-4","article-title":"Structural changes of gut microbiota in Parkinson\u2019s disease and its correlation with clinical features.","volume":"60","author":"Li","year":"2017","journal-title":"Sci. China Life Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.parkreldis.2018.05.007","article-title":"Gut microbiota in patients with Parkinson\u2019s disease in southern China.","volume":"53","author":"Lin","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"B38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.parkreldis.2019.08.010","article-title":"The gut microbiota: a novel therapeutic target in Parkinson\u2019s disease?","volume":"66","author":"Lubomski","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jad.2020.09.032","article-title":"Depression in Parkinson\u2019s disease: perspectives from an Australian cohort.","volume":"277","author":"Lubomski","year":"","journal-title":"J. Affective Disord."},{"key":"B40","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00415-020-09723-5","article-title":"Gastrointestinal dysfunction in Parkinson\u2019s disease.","volume":"267","author":"Lubomski","year":"","journal-title":"J. Neurol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.673816","article-title":"Cognitive influences in Parkinson\u2019s disease patients and their caregivers: perspectives from an Australian cohort.","volume":"12","author":"Lubomski","year":"","journal-title":"Front. Neurol."},{"key":"B42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.14802\/jmd.20079","article-title":"Health-related quality of life in Parkinson\u2019s disease patients and their caregivers.","volume":"14","author":"Lubomski","year":"","journal-title":"J. Mov. Disord."},{"key":"B43","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jocn.2013.12.016","article-title":"Sex differences in Parkinson\u2019s disease.","volume":"21","author":"Lubomski","year":"2014","journal-title":"J. Clin. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jocn.2012.05.015","article-title":"A cross-sectional study of clinical management, and provision of health services and their utilisation, by patients with Parkinson\u2019s disease in urban and regional Victoria.","volume":"20","author":"Lubomski","year":"2013","journal-title":"J. Clin. Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1136\/jnnp-2014-307822","article-title":"Hospitalisation and comorbidities in Parkinson\u2019s disease: a large Australian retrospective study.","volume":"86","author":"Lubomski","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"B46","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1007\/s00415-019-09320-1","article-title":"Parkinson\u2019s disease and the gastrointestinal microbiome.","volume":"267","author":"Lubomski","year":"2020","journal-title":"J. Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s00415-021-10657-9","article-title":"The impact of device-assisted therapies on the gut microbiome in Parkinson\u2019s disease.","volume":"269","author":"Lubomski","year":"","journal-title":"J. Neurol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6323","article-title":"Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism.","volume":"364","author":"Maini Rekdal","year":"2019","journal-title":"Science"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1017\/s0033291700009934","article-title":"Clinical applications of visual analogue scales: a critical review.","volume":"18","author":"McCormack","year":"1988","journal-title":"Psychol. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.4103\/1673-5374.308089","article-title":"Short-chain fatty acids in the context of Parkinson\u2019s disease.","volume":"16","author":"Metzdorf","year":"2021","journal-title":"Neural Regen. Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1046\/j.1365-2036.1998.00404.x","article-title":"The leeds dyspepsia questionnaire: a valid tool for measuring the presence and severity of dyspepsia.","volume":"12","author":"Moayyedi","year":"1998","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/mds.27304","article-title":"A controversy on the role of short-chain fatty acids in the pathogenesis of Parkinson\u2019s disease.","volume":"33","author":"Mulak","year":"2018","journal-title":"Mov. Disord."},{"key":"B53","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/mds.28119","article-title":"Meta-analysis of gut dysbiosis in Parkinson\u2019s disease.","volume":"35","author":"Nishiwaki","year":"2020","journal-title":"Mov. Disord."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.628845","article-title":"Increased added sugar consumption is common in Parkinson\u2019s disease.","volume":"8","author":"Palavra","year":"2021","journal-title":"Front. Nutrition"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short Chain Fatty Acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases.","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front. Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s10517-017-3700-7","article-title":"Analysis of gut microbiota in patients with Parkinson\u2019s disease.","volume":"162","author":"Petrov","year":"2017","journal-title":"Bull. Exp. Biol. Med."},{"key":"B58","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.parkreldis.2010.08.003","article-title":"Gastrointestinal dysfunction in Parkinson\u2019s disease.","volume":"17","author":"Pfeiffer","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"B59","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.parkreldis.2019.06.003","article-title":"Dysbiosis of gut microbiota in a selected population of Parkinson\u2019s patients.","volume":"65","author":"Pietrucci","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"B60","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/mds.24996","article-title":"Identifying prodromal Parkinson\u2019s disease: pre-motor disorders in Parkinson\u2019s disease.","volume":"27","author":"Postuma","year":"2012","journal-title":"Mov. Disord."},{"key":"B61","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2018.02.016","article-title":"Alteration of the fecal microbiota in Chinese patients with Parkinson\u2019s disease.","volume":"70","author":"Qian","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00137","article-title":"Gut microbiota altered in mild cognitive impairment compared with normal cognition in sporadic Parkinson\u2019s disease.","volume":"11","author":"Ren","year":"2020","journal-title":"Front. Neurol."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00037","article-title":"Exploring braak\u2019s hypothesis of parkinson\u2019s disease.","volume":"8","author":"Rietdijk","year":"2017","journal-title":"Front. Neurol."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00156-z","article-title":"Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation.","volume":"7","author":"Romano","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1469.e12","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease.","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1212\/WNL.0b013e3181c34af5","article-title":"Medical records documentation of constipation preceding Parkinson disease: a case-control study.","volume":"73","author":"Savica","year":"2009","journal-title":"Neurology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype.","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov. Disord."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.636545","article-title":"The association between the gut microbiota and parkinson\u2019s disease, a meta-analysis.","volume":"13","author":"Shen","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nrgastro.2016.110","article-title":"Diagnosis: Rome IV criteria for FGIDs - an improvement or more of the same?","volume":"13","author":"Sood","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.25982","article-title":"Gut microbial ecosystem in parkinson disease: new clinicobiological insights from multi-omics.","volume":"89","author":"Tan","year":"2021","journal-title":"Ann. Neurol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease.","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"key":"B72","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","article-title":"Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls.","volume":"32","author":"Unger","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08294-y","article-title":"Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson\u2019s disease.","volume":"10","author":"van Kessel","year":"2019","journal-title":"Nat. Commun."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-020-0112-6","article-title":"Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens.","volume":"6","author":"Wallen","year":"2020","journal-title":"NPJ Parkinsons Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.","volume":"30","author":"Ware","year":"1992","journal-title":"Med. Care"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-019-0100-x","article-title":"Effect of Parkinson\u2019s disease and related medications on the composition of the fecal bacterial microbiota.","volume":"5","author":"Weis","year":"2019","journal-title":"NPJ Parkinsons Dis."},{"key":"B77","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1128\/jb.173.2.697-703.1991","article-title":"16S ribosomal DNA amplification for phylogenetic study.","volume":"173","author":"Weisburg","year":"1991","journal-title":"J Bacteriol."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1101\/2021.11.10.21266194","article-title":"NEMoE: a nutrition aware regularized mixture of experts model addressing diet-cohort heterogeneity of gut microbiota in Parkinson\u2019s disease.","author":"Xu","year":"2021","journal-title":"medRxiv."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-016-2821-1","article-title":"Intestinal microbiota and chronic constipation.","volume":"5","author":"Zhao","year":"2016","journal-title":"Springerplus"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.881872\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T11:52:48Z","timestamp":1652269968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.881872\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":79,"alternative-id":["10.3389\/fnagi.2022.881872"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2022.881872","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"article-number":"881872"}}